Investments
40Funds
3About Digitalis Ventures
Digitalis Ventures is a venture capital firm focused on investing in seed- and venture-stage companies building technology-enabled solutions to complex problems particularly in the area of human health. Digitalis Ventures (f/k/a Mars Ventures) spun out of Mars, Inc. in February 2016. Digitalis Ventures maintains a strategic affiliation with Mars allowing portfolio companies exposure to the global food giant.
Digitalis Ventures Headquarter Location
640 Eighth Avenue 15th Floor, Suite A
New York, New York, 10036,
United States
Latest Digitalis Ventures News
May 12, 2022
Nuvig Therapeutics , a Redwood City, CA-based developer of therapies that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function, raised $47M in Series A funding. The round was led by Novo Holdings A/S and Platanus, with participation from Bristol Myers Squibb, Digitalis Ventures, and Mission BioCapital. The company intends to use the funds to expand its development efforts. Led by Pamela Conley, Ph.D., Chief Executive Officer, Nuvig Therapeutics offers protein therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of immune therapeutics for chronic inflammatory and autoimmune diseases. FinSMEs
Digitalis Ventures Investments
40 Investments
Digitalis Ventures has made 40 investments. Their latest investment was in Nuvig Therapeutics as part of their Series A on May 5, 2022.
Digitalis Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/11/2022 | Series A | Nuvig Therapeutics | $47M | Yes | 3 | |
2/15/2022 | Series A | Terray Therapeutics | $60M | No | 8 | |
1/31/2022 | Seed VC | Ness | $15.5M | Yes | 2 | |
1/18/2022 | Seed VC | |||||
12/22/2021 | Series B |
Date | 5/11/2022 | 2/15/2022 | 1/31/2022 | 1/18/2022 | 12/22/2021 |
|---|---|---|---|---|---|
Round | Series A | Series A | Seed VC | Seed VC | Series B |
Company | Nuvig Therapeutics | Terray Therapeutics | Ness | ||
Amount | $47M | $60M | $15.5M | ||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 3 | 8 | 2 |
Digitalis Ventures Fund History
3 Fund Histories
Digitalis Ventures has 3 funds, including Companion Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
3/9/2018 | Companion Fund | Multi-Stage Venture Capital | Closed | $100M | 1 |
1/4/2017 | Digitalis Ventures Fund I | ||||
Digitalis Seed Fund |
Closing Date | 3/9/2018 | 1/4/2017 | |
|---|---|---|---|
Fund | Companion Fund | Digitalis Ventures Fund I | Digitalis Seed Fund |
Fund Type | Multi-Stage Venture Capital | ||
Status | Closed | ||
Amount | $100M | ||
Sources | 1 |
Digitalis Ventures Team
1 Team Member
Digitalis Ventures has 1 team member, including current Managing Partner, Geoffrey W. Smith.
Name | Work History | Title | Status |
|---|---|---|---|
Geoffrey W. Smith | Managing Partner | Current |
Name | Geoffrey W. Smith |
|---|---|
Work History | |
Title | Managing Partner |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.